PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 31 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $101,000 | +36.5% | 101,000 | +36.5% | 0.00% | – |
| Q3 2017 | $74,000 | +516.7% | 74,000 | +516.7% | 0.00% | – |
| Q2 2017 | $12,000 | +100.0% | 12,000 | +100.0% | 0.00% | – |
| Q1 2017 | $6,000 | -99.6% | 6,000 | -99.6% | 0.00% | – |
| Q4 2016 | $1,448,000 | +6481.8% | 1,486,000 | +6360.9% | 0.00% | – |
| Q3 2016 | $22,000 | 0.0% | 23,000 | 0.0% | 0.00% | – |
| Q2 2016 | $22,000 | +29.4% | 23,000 | +21.1% | 0.00% | – |
| Q1 2016 | $17,000 | +750.0% | 19,000 | +850.0% | 0.00% | – |
| Q3 2015 | $2,000 | -97.3% | 2,000 | -97.4% | 0.00% | – |
| Q2 2015 | $74,000 | +25.4% | 78,000 | +25.8% | 0.00% | – |
| Q1 2015 | $59,000 | +59.5% | 62,000 | +63.2% | 0.00% | – |
| Q4 2014 | $37,000 | +105.6% | 38,000 | +100.0% | 0.00% | – |
| Q3 2014 | $18,000 | +12.5% | 19,000 | +35.7% | 0.00% | – |
| Q2 2014 | $16,000 | +6.7% | 14,000 | 0.0% | 0.00% | – |
| Q1 2014 | $15,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|